X0206 3 2014-06-19 0 0001510580 Kite Pharma, Inc. KITE 0001296549 Belldegrun Arie C/O KITE PHARMA, INC. 2225 COLORADO AVENUE SANTA MONICA CA 90404 1 1 1 0 Chairman, President and CEO Common Stock 2380129 D Common Stock 1240000 I See Footnote Common Stock 1233750 I See Footnote Series A Convertible Preferred Stock Common Stock 158716 I See footnote Series A Convertible Preferred Stock Common Stock 428534 I See footnote Series A Convertible Preferred Stock Common Stock 396791 I See footnote Series A Convertible Preferred Stock Common Stock 539636 I See footnote The securities are held in the name of Bioeast, LLC, of which the reporting person is a managing member. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. The securities are held in the name of Arie and Rebecka Belldegrun as Trustees of the Belldegrun Family Trust dated February 18, 1994. The Series A Convertible Preferred Stock is convertible on a 1-for-1 basis and has no expiration date. The securities are held in the name of The Arie Belldegrun MD, Inc. Profit Sharing Plan, for which the reporting person serves as trustee. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. The securities are held in the name of MDRB Partnership, L.P., of which the reporting person is a managing partner. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. /s/ Arie Belldegrun 2014-06-19